FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Alexion

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states. Alexion Pharmaceuticals, Inc achieved its new 52 week high price of $83.88 where it was opened at $81.39 up 3.03 points or +3.77% by closing at $83.44.

Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) achieved its new 52 week high price of $80.97 where it was opened at $80.35 up 1.10 points or +1.41% by closing at $78.88. ALXN transacted shares during the day were over 1.16 million shares however it has an average volume of 1.16 million shares.

Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) (is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states. Alexion Pharmaceuticals, Inc achieved its new 52 week high price of $73.05 where it was opened at $70.95 UP 2.12 points or +3.02% by closing at $72.41.

Alexion Pharmaceuticals, Inc (NASDAQ:ALXN) (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states. Alexion Pharmaceuticals, Inc achieved its new 52 week high price of $72.25 where it was opened at $71.46 UP 0.52 points or +0.73% by closing at $71.50.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) achieved its new 52 week high price of $70.42 where it was opened at $68.24 up +1.18 points or +1.73% by closing at $69.56. ALXN transacted shares during the day were over 1.68 million shares however it has an average volume of 1.70 million shares.

PDI, Inc. (Nasdaq:PDII) announced that Nancy Lurker, the company's chief executive officer, is scheduled to present at the UBS Global Life Sciences Conference at 1:00 pm ET on September 19, 2011 at the Grand Hyatt New York.

PDI, Inc. provides outsourced promotional services to various companies in the pharmaceutical, biotechnology, and healthcare industries in the United States.

****

Landstar System Inc. (Nasdaq:LSTR) reported 2010 fourth quarter net income of $24.1 million, or $0.50 per diluted share, compared to net income of $18.6 million, or $0.37 per diluted share, for the 2009 fourth quarter. Revenue for the 2010 fourth quarter was $587.5 million compared to $547.7 million in the 2009 fourth quarter.

ADVERTISE WITH US